Keeler 02/04 Changes in Care and Outcomes for Patients with Congestive Heart Failure: The Improving Chronic Illness Care Evaluation David W. Baker, MD,

Slides:



Advertisements
Similar presentations
Decimal Addition & Subtraction Like Youve Never Seen Pamela Weber pamelawharris.com
Advertisements

Trend for Precision Soil Testing % Zone or Grid Samples Tested compared to Total Samples.
AGVISE Laboratories %Zone or Grid Samples – Northwood laboratory
1 Yell / The Law and Special Education, Second Edition Copyright © 2006 by Pearson Education, Inc. All rights reserved.
DAT2343 File Dump Analysis © Alan T. Pinck / Algonquin College; 2003.
FT in diagnostic of HBV Prognostic Value of FibroTest in HCV Ngo et al, ClinChem 2006 A Prospective Analysis of the prognostic value of biomarkers (FirboTest)
1_Panel Production. 380 pannelli 45 giorni di produzione = 8.4 pannelli/day.
Feichter_DPG-SYKL03_Bild-01. Feichter_DPG-SYKL03_Bild-02.
Ten years of the CHD NSF Professor Roger Boyle CBE National Director for Heart Disease and Stroke Department of Health.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 116.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Appendix 01.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 40.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 28.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 44.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 29.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 38.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 58.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 75.
Chapter 1 Image Slides Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
Ph.D. Completion and Attrition CGS Board of Directors December 4, 2007.
Disability status in Ethiopia in 1984, 1994 & 2007 population and housing sensus Ehete Bekele Seyoum ESA/STAT/AC.219/25.
VALIDATING AHRQ PATIENT SAFETY INDICATORS with the VA NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM POSTOPERATIVE ADVERSE EVENTS Dennis Tsilimingras, M.D.,
Therapy Disruptions and Physical Restraints in ICU Settings: Implications for Quality Initiatives Lorraine C. Mion, PhD, RN, FAAN Ann F. Minnick, PhD,
Chronic Care Model Implementation Emphases M. L. Pearson, 1 S. Wu, 1 S.M. Shortell, 2 J.A. Marsteller, 3 P.J. Mendel, 1 M. Lin, 2 E.B. Keeler 1 1 RAND.
Lessons Learned through Research: Do Hospitals and Ambulatory Centers Follow Guideline Recommended Care Nancy Albert, PhD, RN, CCNS, CCRN, NE-BC, FAHA,
How can we reduce central obesity during a cardiac rehabilitation program? Noeleen Fallon CNM 2 Cardiac Rehabilitation Department, AMNCH MSc Cardiac Rehabilitation.
Performance of Hedges & Long Futures Positions in CBOT Corn Goodland, Kansas March 2, 2009 Daniel OBrien, Extension Ag Economist K-State Research and Extension.
THE QUIZ. Question 1: Which of these is the same as 25/1000? 0.25, 0.25, 0.025, 25.0, 25/ /100 Question 2: What is 25 times 7? , 175,
Version 0.3, 28 January 2004 Slide: 1 APPLICATIONS OF METEOSAT SECOND GENERATION (MSG) DETECTION OF CONTRAILS Author:Jochen Kerkmann (EUMETSAT)
Break Time Remaining 10:00.
The basics for simulations
KARACHI FASHION WEEK CHAPTER 3 JANUARY 27 – 30, 2011 FASHION RUNWAY SHOW FASHION RUNWAY SHOW BRAND PRESENTATIONS BRAND PRESENTATIONS FASHION BRANDS EXHIBITIONS.
The Pecan Market How long will prices stay this high?? Brody Blain Vice – President.
1 Prediction of electrical energy by photovoltaic devices in urban situations By. R.C. Ott July 2011.
15. Oktober Oktober Oktober 2012.
Cardiac Insufficiency Bisoprolol Study (CIBIS III) Trial
Performance of units These slides complement the article How journal rankings can suppress interdisciplinary research. A comparison between innovation.
Version 1.0, 30 November 2004 Slide: 1 APPLICATIONS OF METEOSAT SECOND GENERATION (MSG) DETECTION OF CONTRAILS Author:Jochen Kerkmann (EUMETSAT)
We are learning how to read the 24 hour clock
Calculating Z-scores A z-score tells you where you are on the generic normal distribution curve Most z-scores are between -3 and 3 (because 99.7% of the.
Efficacy and Safety of Exercise Training as a Treatment Modality in Patients With Chronic Heart Failure: Results of A Randomized Controlled Trial Investigating.
2.10% more children born Die 0.2 years sooner Spend 95.53% less money on health care No class divide 60.84% less electricity 84.40% less oil.
: 3 00.
5 minutes.
The Effect of Peloid Application in Out-patient Setting on Knee Osteoarthritis Results of a Pilot Study E Odabaşı, R Tekin, H Erdem, İ.Şimşek, M Turan.
Improving Office Care for Chest Pain Thomas D. Sequist, MD MPH Associate Professor of Medicine and Health Care Policy Brigham and Women ’ s Hospital, Division.
New Lesions versus Growth of Existing Disease: Does it impact prognosis? Axel Grothey¹, James Heun¹, Megan Branda¹, Richard M. Goldberg², Dan Sargent¹.
Edward P. Sloan, MD, MPH, FACEP Research Lecture : Basic Statistics.
Basic Statistics: The Three Things You Need to Know In Order to Complete Your Project.
Clock will move after 1 minute
Chandy Lou P. Malong, MD & John S. Delgado, MD
Select a time to count down from the clock above
Murach’s OS/390 and z/OS JCLChapter 16, Slide 1 © 2002, Mike Murach & Associates, Inc.
Patient-reported Measures: KCCQ and CHF outcomes Aanand D. Naik, MD Houston Health Services Research and Development Center of Excellence.
Effect Size and Statistical Power Analysis in Behavioral and Educational Research Effect size 1 (P. Onghena) a.m. Effect size 2 (W. Van den.
1 Mark Huffman, MD, MPH Northwestern University Feinberg School of Medicine Northwestern Memorial Hospital Healthy Transitions 21 November 2013 Blood Pressure.
Schutzvermerk nach DIN 34 beachten 05/04/15 Seite 1 Training EPAM and CANopen Basic Solution: Password * * Level 1 Level 2 * Level 3 Password2 IP-Adr.
1 SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY (ANBP-2) Enalapril/ACEI vs. HCTZ, n = 6,083 Randomized, open-label (blinded endpoint review) All CV events.
The Relationship Between CMS Quality Indicators and Long-term Outcomes Among Hospitalized Heart Failure Patients Mark Patterson, Ph.D., M.P.H. Post-doctoral.
Overview of the CVD Risk Reduction Demonstration Project Kelly Acton, MD, MPH, FACP IHS Division of Diabetes Treatment & Prevention.
Redwood Community Care Organization Data Capture for ACO Quality Measures.
CHARM-Preserved: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Preserved Purpose To determine whether the angiotensin.
Use of Information Technology for Precision Performance Measurement and Focused Quality Improvement David W. Baker, MD MPH Chief, General Internal Medicine.
Improving Hypertension Quality Measurement Using Electronic Health Records S Persell, AN Kho, JA Thompson, DW Baker Feinberg School of Medicine Northwestern.
Quality & Service Recognition Program A PPO Incentive Program for Quality Richard S. Chung, MD SVP, Health Services Division BCBS of Hawaii (Hawaii Medical.
Circulating Long-Chain ω-3 Fatty Acids and Incidence of Congestive Heart Failure in Older Adults: The Cardiovascular Health Study Funded by: National Institutes.
Relationship of background ACEI dose to benefits of candesartan in the CHARM-Added trial.
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease (HOPE-3 trial) R4. 박은지 / PF. 정혜문 Salim Yusuf, M.B., B.S., D.Phil.,
Volume 146, Issue 5, Pages (November 2014)
ANNIE RUTTER, MD, MS & ELIZABETH MEZA, MD UNC-CHAPEL HILL
Presentation transcript:

Keeler 02/04 Changes in Care and Outcomes for Patients with Congestive Heart Failure: The Improving Chronic Illness Care Evaluation David W. Baker, MD, MPH Chief, Division of General Internal Medicine Feinberg School of Medicine, Northwestern University Chicago, Illinois June 6, 2004

A5162b-2 03/04 Keeler 02/04 Changes in Processes of Care: Methods for Chart Reviews 4 participant organizations (PART): N = control organizations (CTRL): N = 228 Charts abstracted at baseline (7/98 to 5/99) & follow-up periods (9/99 to 8/00). –23 Quality Indicators: Dx, Rx, F/u, Counseling Determined changes in processes from baseline to follow-up period. –Compared differences b/n PART vs. CTRL.

A5162b-3 03/04 Keeler 02/04 Baseline Characteristics PARTCTRL Age, mean yrs6766 Male6864 New CHF Diagnosis15*8 LVEF < 40 %4748 Mean # of Chronic Dz Mean # of Visits/Year Hospitalized3536 * p = 0.01

A5162b-4 03/04 Keeler 02/04 Participants & Controls Had Similar Changes in Diagnostic Testing PART (abs % chg) CTRL (abs % chg) p LVEF measured Cr measured if on digoxin BP measured at MD visit LDL measured if CAD

A5162b-5 03/04 Keeler 02/04 Participants Increased Use of ACE Inhibitors and Lipid-Lowering Rx PART (abs % chg) CTRL (abs % chg) p ACEI for LVEF < 40 %13-5<.001 Beta blockade for LVEF < 40 % Anticoagulation for atrial fibrillation Lipid-lowering therapy for CAD 71<.001

A5162b-6 03/04 Keeler 02/04 Participants Increased Counseling PARTCTRLP Medication24<.0001 Diet33-4<.0001 Exercise24-2<.0001 Smoking Weight loss30-2<.0001 Disease management414<.0001 Weight management243<.0001 Goal setting40<.0001

A5162b-7 03/04 Keeler 02/04 Conclusions from Chart Review Organizations that participated in the CHF Collaborative improved more than controls: –ACE Inhibitors for pts w/ LVEF  0.40 –Lipid lowering therapy for pts w/ CAD –All aspects of counseling x/ smoking No difference in change over time for: –LVEF measurement –Beta blocker use, anticoagulation –Other diagnostic tests, follow-up

A5162b-8 03/04 Keeler 02/04 Limitations of Results from Chart Review Brief period for participants to improve care. –Differences between PART and CTRL groups may have increased over time. Large improvements in care for pts in CTRL group, perhaps due to other QI forces. Improvement in patient counseling could be due to better documentation, gaming.

A5162b-9 03/04 Keeler 02/04 Differences in Communication, Education, and Health Status: Methods for Patient Surveys 6 participant organizations (PART): N = control organizations (CTRL): N = 414 Telephone interviews conducted with patients approximately 10 months after collaborative. Survey developed for this study. Determined differences b/n PART vs. CTRL.

A5162b-10 03/04 Keeler 02/04 CHF Team  Satisfaction  Communication  Education  ACCESS  QUALITY  Knowledge  SELF- MANAGEMENT  Self-Efficacy Improved Health Outcomes Conceptual Model of How a CHF Team Acts to Improve Self-management, Access, Quality, and Health Outcomes.

A5162b-11 03/04 Keeler 02/04 Domains Included in Questionnaire Communication (4 item scale) Satisfaction (CAHPS) Education (15 items) Knowledge (15 items): sx, high salt foods, general knowledge and self-management. Behaviors: daily weights, low salt diet. Self-efficacy Generic (SF12) and CHF-specific health status (7 item scale)

A5162b-12 03/04 Keeler 02/04 Participant Characteristics PARTCTRL Age  65 (%) 6163 Female (%)5253 White7073 Less than High School4041 History of CAD, %6469 History of CABG, %2422 Hx of Revascularization %6661 Primary Care Physician30*39 *p = 0.02

A5162b-13 03/04 Keeler 02/04 Participants Had Better Provider-Patient Communication PART mean CTRL mean p Gave me choices and options about my treatment Gave me confidence that I can make changes in my life to control my HF Were interested in my questions <0.01 Regularly reviewed how I am doing in managing all aspects of my HF <0.01

A5162b-14 03/04 Keeler 02/04 Participants Reported More Education About Lifestyle and Monitoring HF ADVISED TO:PARTCTRLp Not use salt when cooking and not to add salt to food Avoid drinking large amounts of water/other fluids Weigh self on a scale every morning and record weight. 8734< 0.01 Exercise regularly.9083<0.01

A5162b-15 03/04 Keeler 02/04 Participants Had Better HF Knowledge* *p < for all comparisons PART (%) CTRL (%) A person with HF should not drink more fluids than normal Someone with HF should check wt at least several times/week Shortness of breath is a sx of HF Swelling of the legs or ankles is a symptom of HF Weight gain is a symptom of HF. 7661

A5162b-16 03/04 Keeler 02/04 Participants Had Better Weight Monitoring, but Similar Diet Compliance PARTCTRLp Has functioning scale at home (% yes). 93%81%<0.01 How frequently checks weight (1-5 scale, mean) <0.01 Took steps to eat low salt diet.88%85%0.35 Success at adhering to low salt diet (1-3 scale, mean)

A5162b-17 03/04 Keeler 02/04 Conclusions from Survey Organizations in the Collaborative had: –Better communication. –Higher self-reports of education received –Higher knowledge, including symptoms of heart failure and weight monitoring –Higher rates of monitoring weight No differences for self-efficacy, satisfaction, low salt diet compliance, and health status. Conclusions limited by lack of baseline data.

A5162b-18 03/04 Keeler 02/04 Final Conclusions from Evaluation Participation in the CHF Collaborative was associated with improvements in care, includ- ing prescribing of recommended therapies and patient self-management support. Chart review and patient survey support each other’s findings that there were large improve- ments in education and counseling. Viewed together, they mitigate the limitations in each.